Arthritis Research UK

We are fortunate to have a dedicated orthopaedic Clinical Studies Group (CSG) hosted by AR UK whose aim is to improve the effectiveness of trauma and orthopaedic surgery in the management of musculoskeletal disease. The CSG encourages and supports the development of large scale clinical studies, especially randomised controlled trials that answer questions about which surgical treatments are most effective and in which patients.

More information on the Metabolic Bone Disease and Musculoskeletal Trauma CSG, including who they are, what they do and how you can get involved, can be found on the slideshow here.

For further detail see arthritisresearchuk.org

Musculoskeletal Conditions and Multimorbidity Report

Arthritis Research UK published a report on 21st July 2017, addressing the rise in multimorbidity (people living with two or more long term conditions) and what this means for musculoskeletal health.

Multimorbidity can have serious implications for quality of life for those living with it and presents challenges for the provision of integrated services from multiple specialities. Likewise, musculoskeletal conditions have a disproportionately negative impact on quality of life, due to long-term pain and functional limitations. This often has an effect on mental health, as well as physical health.

The report argues that musculoskeletal health, as well as long-term pain and functional limitations, should be adequately considered in the analysis of and planning for multimorbidity services. The report advocates for ‘people-centred care’ as a vital part of offering coordinated services to those who need long-term care. To address this, it makes recommendations in the following areas:

  • Identification: Tools in multimorbidity programmes should include pain and its impact, functional abilities, and capability to manage.
  • Data collection: Public Health England and other bodies should ensure data collection, analysis and publication raises awareness of multimorbidity (and relevance to musculoskeletal health).
  • Planning and commissioning: Local planners and commissioners should identify the needs of multimorbidity and musculoskeletal patients and reflect these in local strategic plans.
  • Care and support planning: Healthcare providers should ensure that care and support planning processes use standardised tools to explore and record pain, functional limitations and how these affect their daily activities.
  • Health promotion: Public Health England should ensure that its information, programmes and campaigns reflect the growing needs related to multimorbidity (and musculoskeletal conditions).
  • Voluntary sector: Disease-specific charities should collaborate to develop resources, programmes, research and partnerships for the changing resulting from multimorbidity.
  • Research agenda: The National Institute for Health Research and research funders should work with partners for research agenda that covers multimorbidity and musculoskeletal conditions.

For further information and to download the report, please visit the Arthritis Research UK website.